166 related articles for article (PubMed ID: 8660799)
1. Mechanism of the development of autoimmune dacryodenitis in the mouse model for primary Sjögren's syndrome.
Takahashi M; Mimura Y; Hamano H; Haneji N; Yanagi K; Hayashi Y
Cell Immunol; 1996 May; 170(1):54-62. PubMed ID: 8660799
[TBL] [Abstract][Full Text] [Related]
2. Biased T cell receptor V beta gene usage during specific stages of the development of autoimmune sialadenitis in the MRL/lpr mouse model of Sjögren's syndrome.
Hayashi Y; Hamano H; Haneji N; Ishimaru N; Yanagi K
Arthritis Rheum; 1995 Aug; 38(8):1077-84. PubMed ID: 7639803
[TBL] [Abstract][Full Text] [Related]
3. A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice.
Haneji N; Hamano H; Yanagi K; Hayashi Y
J Immunol; 1994 Sep; 153(6):2769-77. PubMed ID: 8077681
[TBL] [Abstract][Full Text] [Related]
4. Role of the ICAM-1/LFA-1 pathway during the development of autoimmune dacryoadenitis in an animal model for Sjögren's syndrome.
Takahashi M; Mimura Y; Hayashi Y
Pathobiology; 1996; 64(5):269-74. PubMed ID: 9068010
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of Sjögren's syndrome-like autoimmune lesions in MRL/lpr mice.
Hayashi Y; Haneji N; Hamano H
Pathol Int; 1994 Aug; 44(8):559-68. PubMed ID: 7952145
[TBL] [Abstract][Full Text] [Related]
6. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjögren's syndrome.
Matsumoto I; Tsubota K; Satake Y; Kita Y; Matsumura R; Murata H; Namekawa T; Nishioka K; Iwamoto I; Saitoh Y; Sumida T
J Clin Invest; 1996 Apr; 97(8):1969-77. PubMed ID: 8621782
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor inhibitor gene expression suppresses lacrimal gland immunopathology in a rabbit model of autoimmune dacryoadenitis.
Zhu Z; Stevenson D; Schechter JE; Mircheff AK; Crow RW; Atkinson R; Ritter T; Bose S; Trousdale MD
Cornea; 2003 May; 22(4):343-51. PubMed ID: 12792478
[TBL] [Abstract][Full Text] [Related]
8. T-cell receptor repertoire of infiltrating T cells in lachrymal glands, salivary glands and kidneys from alymphoplasia (aly) mutant mice: a new model for Sjögren's syndrome.
Furukawa M; Sakamoto A; Kita Y; Ohishi Y; Matsumura R; Tsubata R; Tsubata T; Iwamoto I; Saito Y; Sumida T
Br J Rheumatol; 1996 Dec; 35(12):1223-30. PubMed ID: 9010048
[TBL] [Abstract][Full Text] [Related]
9. Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice.
Jabs DA; Lee B; Whittum-Hudson JA; Prendergast RA
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):826-31. PubMed ID: 10711700
[TBL] [Abstract][Full Text] [Related]
10. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background.
Czerwinski S; Mostafa S; Rowan VS; Azzarolo AM
Exp Eye Res; 2014 Nov; 128():15-22. PubMed ID: 25218176
[TBL] [Abstract][Full Text] [Related]
11. Effector mechanism of experimental autoimmune sialadenitis in the mouse model for primary Sjögren's syndrome.
Hayashi Y; Haneji N; Hamano H; Yanagi K; Takahashi M; Ishimaru N
Cell Immunol; 1996 Aug; 171(2):217-25. PubMed ID: 8806790
[TBL] [Abstract][Full Text] [Related]
12. Submandibular and lacrimal gland immunoglobulin in the C3H.MRL-Faslpr autoimmune mouse model of Sjögren's syndrome.
Trune DR; Leedy DA
Laryngoscope; 1998 Nov; 108(11 Pt 1):1729-32. PubMed ID: 9818834
[TBL] [Abstract][Full Text] [Related]
13. High incidence of autoimmune dacryoadenitis in male non-obese diabetic (NOD) mice depending on sex steroid.
Takahashi M; Ishimaru N; Yanagi K; Haneji N; Saito I; Hayashi Y
Clin Exp Immunol; 1997 Sep; 109(3):555-61. PubMed ID: 9328136
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the T-cell receptor Valpha repertoire and cytokine gene expression in Sjögren's syndrome.
Ajjan RA; McIntosh RS; Waterman EA; Watson PF; Franklin CD; Yeoman CM; Weetman AP
Br J Rheumatol; 1998 Feb; 37(2):179-85. PubMed ID: 9569073
[TBL] [Abstract][Full Text] [Related]
15. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.
Fox RI; Kang HI; Ando D; Abrams J; Pisa E
J Immunol; 1994 Jun; 152(11):5532-9. PubMed ID: 8189070
[TBL] [Abstract][Full Text] [Related]
16. Anti-120-kDa alpha-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren's syndrome.
Yanagi K; Ishimaru N; Haneji N; Saegusa K; Saito I; Hayashi Y
Eur J Immunol; 1998 Oct; 28(10):3336-45. PubMed ID: 9808203
[TBL] [Abstract][Full Text] [Related]
17. Innate Immune Signaling Induces IL-7 Production, Early Inflammatory Responses, and Sjögren's-Like Dacryoadenitis in C57BL/6 Mice.
Zhou J; Jin JO; Du J; Yu Q
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7831-8. PubMed ID: 26658504
[TBL] [Abstract][Full Text] [Related]
18. Histologic examination of the NOD-mouse lacrimal glands, a potential model for idiopathic autoimmune dacryoadenitis in Sjogren's syndrome.
Moore PA; Bounous DI; Kaswan RL; Humphreys-Beher MG
Lab Anim Sci; 1996 Feb; 46(1):125-8. PubMed ID: 8699811
[No Abstract] [Full Text] [Related]
19. Single cell analysis of T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
Matsumoto I; Okada S; Kuroda K; Iwamoto I; Saito Y; Tokuhisa T; Nishioka K; Sumida T
Int J Mol Med; 1999 Nov; 4(5):519-27. PubMed ID: 10534575
[TBL] [Abstract][Full Text] [Related]
20. Severe focal sialadenitis and dacryoadenitis in NZM2328 mice induced by MCMV: a novel model for human Sjögren's syndrome.
Ohyama Y; Carroll VA; Deshmukh U; Gaskin F; Brown MG; Fu SM
J Immunol; 2006 Nov; 177(10):7391-7. PubMed ID: 17082658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
